Nicholas Investment Partners’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-320,168
Closed -$11.3M 198
2022
Q3
$11.3M Buy
320,168
+48,142
+18% +$2.04M 1.05% 35
2022
Q2
$9.51M Sell
272,026
-7,838
-3% -$278K 0.9% 38
2022
Q1
$13.8M Buy
279,864
+114,813
+70% +$6.36M 0.98% 33
2021
Q4
$12.8M Buy
165,051
+30,989
+23% +$3.18M 0.81% 45
2021
Q3
$14.3M Sell
134,062
-48,905
-27% -$5.6M 1.05% 24
2021
Q2
$24.4M Buy
182,967
+20,232
+12% +$2.35M 1.53% 9
2021
Q1
$20.2M Sell
162,735
-16,140
-9% -$2.45M 1.4% 17
2020
Q4
$25.3M Sell
178,875
-90,645
-34% -$10.1M 1.95% 3
2020
Q3
$20.5M Buy
269,520
+225,697
+515% +$14.1M 2.21% 6
2020
Q2
$1.99M Sell
43,823
-70,349
-62% -$2.52M 0.4% 98
2020
Q1
$3.49M Buy
+114,172
New +$3.07M 0.68% 56

Other funds holding TWST

Nicholas Investment Partners's TWST Position: Q4 2022 in Review

Nicholas Investment Partners sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 320,168 shares — an estimated $11.3M sold.

Nicholas Investment Partners first reported a position in TWST in Q1 2020 and held it in 11 quarters. The position peaked at $25.3M in Q4 2020. 199 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Nicholas Investment Partners reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 320,168 Twist Bioscience shares in Q4 2022, an estimated $11.3M.
  • Nicholas Investment Partners first reported a position in Twist Bioscience in Q1 2020 and held it in 11 quarters.
  • Nicholas Investment Partners's Twist Bioscience position peaked at $25.3M in Q4 2020.
  • 199 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.